Daniel James George, MD

Professor of Medicine
Professor in Surgery
Member of the Duke Cancer Institute
Campus mail Duke Box 103861, Durham, NC 27710
Phone (919) 668-4615
Email address daniel.george@duke.edu

Education and Training

  • Fellow in Medical Oncology, Medicine, Johns Hopkins University, 1995 - 1998
  • Medical Resident, Medicine, Johns Hopkins University, 1992 - 1995
  • M.D., Duke University, 1992

Grants

Publications

Armstrong, Andrew J., Susan Halabi, Jun Luo, David M. Nanus, Paraskevi Giannakakou, Russell Z. Szmulewitz, Daniel C. Danila, et al. “Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.” J Clin Oncol 37, no. 13 (May 1, 2019): 1120–29. https://doi.org/10.1200/JCO.18.01731.

PMID
30865549
Full Text

George, D. J. “Outcomes.” Clinical Advances in Hematology and Oncology 17, no. 5 (May 1, 2019).

Scholars@Duke

Den, Robert B., Daniel George, Christopher Pieczonka, and Megan McNamara. “Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer: Practical Management Issues for Patient Selection.” Am J Clin Oncol 42, no. 4 (April 2019): 399–406. https://doi.org/10.1097/COC.0000000000000528.

PMID
30844849
Full Text

George, D. J. “Talk to me.” Clinical Advances in Hematology and Oncology 17, no. 3 (March 1, 2019).

Scholars@Duke

George, Daniel J., Jean-Francois Martini, Michael Staehler, Robert J. Motzer, Ahmed Magheli, Frede Donskov, Bernard Escudier, et al. “Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis.” Clin Cancer Res 25, no. 4 (February 15, 2019): 1165–73. https://doi.org/10.1158/1078-0432.CCR-18-1724.

PMID
30401688
Full Text

Halabi, Susan, Sandipan Dutta, Catherine M. Tangen, Mark Rosenthal, Daniel P. Petrylak, Ian M. Thompson, Kim N. Chi, et al. “Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel.” J Clin Oncol 37, no. 5 (February 10, 2019): 403–10. https://doi.org/10.1200/JCO.18.01279.

PMID
30576268
Full Text

Conroy, Jeffrey M., Sarabjot Pabla, Mary K. Nesline, Sean T. Glenn, Antonios Papanicolau-Sengos, Blake Burgher, Jonathan Andreas, et al. “Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors.” J Immunother Cancer 7, no. 1 (January 24, 2019): 18. https://doi.org/10.1186/s40425-018-0489-5.

PMID
30678715
Full Text

George, D. J. “Clinical advances: Past and present.” Clinical Advances in Hematology and Oncology 17, no. 1 (January 1, 2019).

Scholars@Duke

Bergerot, Cristiane Decat, Dena Battle, Paulo Gustavo Bergerot, Nazli Dizman, Eric Jonasch, Hans J. Hammers, Daniel J. George, et al. “Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma.” Front Oncol 9 (2019): 11. https://doi.org/10.3389/fonc.2019.00011.

PMID
30723705
Full Text

Pages